Amrutanjan Health Care Limited (AMRUTANJAN)

Price635.95 2.00 (0.32%)52 Week High775.45
ISININE098F0103152 Week Low554.05
IndustryPharmaceuticals: OtherVolume32,284
SectorHealth TechnologyP/E Ratio TTM43.12
Market Cap18.5 B1 Year Beta0.88
Technical Rating of

Amrutanjan Health Care Limited (AMRUTANJAN) logo
  • Amrutanjan Health Care Limited (AMRUTANJAN) is an Indian pharmaceutical company headquartered in Hyderabad, India. It was incorporated in 1965.
  • The company’s initial focus was on the manufacturing of pain relief balms. Amrutanjan has since expanded its operations to include a wide range of over-the-counter (OTC) products, including cough syrups, cold remedies, and skin care products.
  • Amrutanjan is one of the leading OTC brands in India. The company’s products are sold across the country and exported to over 50 countries.
  • Amrutanjan is a privately held company. The company’s parent company is the Amrutanjan Group, which is a diversified conglomerate with interests in pharmaceuticals, real estate, and education.
  • Amrutanjan is well-positioned for continued growth in the future. The company is targeting to expand its product portfolio and increase its market share.

Here are some of the key points about Amrutanjan Health Care Limited:

  • Founded in 1965
  • Headquartered in Hyderabad, India
  • One of the leading OTC brands in India
  • Products sold across the country and exported to over 50 countries
  • Privately held company
  • Well-positioned for continued growth in the future
          

Amrutanjan Health Care Limited (AMRUTANJAN) Chart

Technical Analysis of Amrutanjan Health Care Limited (AMRUTANJAN)

Moving Averages

PeriodSimpleExponential
MA 5635.00634.76
MA 10635.49634.32
MA 20629.44632.72
MA 30625.03633.45
MA 50639.87635.59
MA 100634.15639.33
MA 200648.74657.41

Moving Average Rating

Technical Indicators

NameValueNameValue
Aroon Up (14)21.43Aroon Down (14)7.14
MACD Level (12, 26)0.85MACD Signal (12, 26)-0.25
Relative Strength Index (7)53.29Relative Strength Index (14)51.71
Stochastic %D (14 3 3)47.85Stochastic %K (14 3 3)47.41
Stochastic RSI Fast (3, 3, 14, 14)46.78Stochastic RSI Slow (3, 3, 14, 14)47.40
Bollinger Upper Band (20)658.65Bollinger Lower Band (20)600.23
Keltner Channels Upper Band (20)663.44Keltner Channels Lower Band (20)601.99
Donchian Channels Upper Band (20)659.90Donchian Channels Lower Band (20)606.55
Ichimoku Conversion Line (9, 26, 52, 26)638.15Ichimoku Base Line (9, 26, 52, 26)630.50
Ichimoku Leading Span A (9, 26, 52, 26)653.35Ichimoku Leading Span B (9, 26, 52, 26)677.27
Positive Directional Indicator (14)22.94Negative Directional Indicator (14)17.27
Volume Weighted Average Price638.67Volume Weighted Moving Average 20633.98

Oscillator Rating

Oscillators

Awesome Oscillator10.44
Ultimate Oscillator (7,14,28)38.93
Money Flow (14)66.68
Chaikin Money Flow (20)-0.09
Commodity Channel Index (20)46.08
Bull Bear Power12.83

High / Low

1 Month659.90606.55
3 Month775.45601.10
6 Month775.45554.05
52 Week775.45554.05
All Time1,024.5541.30

Volume

Volume32,284.00
Average 10 D31,880.60
Average 30 D41,120.00
Average 60 D91,530.92
Average 90 D83,284.56

Change/Volatility

Change2.00 (0.32%)
Change 1W-8.10 (-1.26%)
Change 1M21.40 (3.48%)
Volatility3.17
Volatility W2.68

Performance

Yesterday-9.96
Weekly-1.20
Monthly3.93
3 Month-0.77
6 Month-1.09
Yearly-12.28
5 Year130.42
All Time1,362.12

Misc.

Average Day Range (14)17.19
Average Directional Index (14)18.73
Average True Range (14)15.01
Williams Percent Range (14)-47.15
Rate Of Change (9)-0.90
Hull Moving Average (9)632.38
Momentum (10)-13.20
Parabolic SAR658.52

PIVOT POINTS of Amrutanjan Health Care Limited (AMRUTANJAN)

NameS3S2S1Pivot PointsR1R2R3
Classic499.92563.32588.93626.72652.33690.12753.52
Fibonacci563.32587.54602.50626.72650.94665.90690.12
Camarilla597.11602.93608.74626.72620.36626.17631.98
Woodie's517.15559.12580.55622.52643.95685.93707.35
DeMark's - - 576.12620.31639.52 - -

Financial Analysis of Amrutanjan Health Care Limited (AMRUTANJAN)

Income Statement

Basic EPS (FY)13.65
Basic EPS (TTM)14.80
EBITDA (Annual YoY Growth)-42.72
EBITDA (Quarterly QoQ Growth)-44.84
EBITDA (Quarterly YoY Growth)115.03
EBITDA (TTM)482.2 M
EBITDA (TTM YoY Growth)-29.35
EPS Diluted (Annual YoY Growth)-40.69
EPS Diluted (FY)13.63
EPS Diluted (Quarterly QoQ Growth)-44.93
EPS Diluted (Quarterly YoY Growth)91.20
EPS Diluted (TTM)14.75
EPS Diluted (TTM YoY Growth)-26.58
Free Cash Flow (Annual YoY Growth)-45.64
Free Cash Flow Margin (FY)5.92
Gross Profit (Annual YoY Growth)-18.64
Gross Profit (FY)1.3 B
Gross Profit (MRQ)244.9 M
Gross Profit (Quarterly QoQ Growth)-31.09
Gross Profit (Quarterly YoY Growth)7.47
Gross Profit (TTM YoY Growth)-11.87
Last Year Revenue (FY)3.8 B
Revenue (Annual YoY Growth)-6.46
Revenue per Employee (FY)3.3 M
Revenue (Quarterly QoQ Growth)-22.38
Revenue (Quarterly YoY Growth)9.74
Revenue (TTM YoY Growth)-3.02
Net Income (Annual YoY Growth)-40.71
Net Income (FY)398.3 M
Net Income (Quarterly QoQ Growth)-44.74
Net Income (Quarterly YoY Growth)91.45
Net Income (TTM YoY Growth)-26.55
Total Revenue (FY)3.8 B

Valuation

Enterprise Value/EBITDA (TTM)38.41
Number of Employees1,150.00
Number of Shareholders72,285.00
Shares Float15.1 M
Price to Book (FY)6.38
Price to Earnings Ratio (TTM)43.12
Price to Revenue Ratio (TTM)4.83
Price to Sales (FY)4.90
Total Shares Outstanding29.2 M
Research & development Ratio (FY)0.31
Selling & Admin expenses Ratio (FY)23.73
Selling & Admin expenses Ratio (TTM)26.56

Balance Sheet

Total Assets (Annual YoY Growth)3.50
Total Debt (Annual YoY Growth)3.32
Total Liabilities (FY)730.9 M
Cash & Equivalents (FY)76.6 M
Cash and short term investments (FY)754.6 M

Operating Metrics

Dividends

Dividend Yield Forward0.73
Dividends Paid (FY)-144,091,000.00
Dividends per Share (FY)4.60

Margins

Net Margin (FY)10.49
Net Margin (TTM)11.17
Gross Margin (FY)35.27
Gross Margin (TTM)37.60
Operating Margin (FY)11.40
Operating Margin (TTM)11.04
Pretax Margin (TTM)14.96

Related Companies (Peers) to Amrutanjan Health Care Limited (AMRUTANJAN)

Price866.40 -10.05 (-1.15%)52 Week High907.70
ISININE406A0103752 Week Low397.20
IndustryPharmaceuticals: OtherVolume1.4 M
SectorHealth TechnologyP/E Ratio TTM25.67
Market Cap513.3 B1 Year Beta0.66
Technical Rating of
Aurobindo Pharma Limited (AUROPHARMA) is an Indian multinational pharmaceutical company headquartered in Hyderabad, India. It was founded in 1986 by P. V. Ramana Rao. Aurobindo’s initial focus was on the manufacturing of generic pharmaceuticals. It has since expanded its operations to include a wide range of products, including APIs, finished dosages, and biosimilars. Aurobindo is more about Aurobindo Pharma Limited (AUROPHARMA)

Price1,185.90 -20.50 (-1.70%)52 Week High1,277.90
ISININE059A0102652 Week Low852.00
IndustryPharmaceuticals: OtherVolume2.8 M
SectorHealth TechnologyP/E Ratio TTM30.77
Market Cap974.5 B1 Year Beta0.06
Technical Rating of
Cipla Limited (CIPLA) is an Indian multinational pharmaceutical company headquartered in Mumbai, India. It was founded in 1935 by Khwaja Abdul Hamied. CIPLA is one of the largest pharmaceutical companies in India and has a global presence, with operations in over 150 countries. The company’s products include generic drugs, branded drugs, and over-the-counter (OTC) products. more about Cipla Limited (CIPLA)

Price336.80 13.60 (4.21%)52 Week High381.00
ISININE101D0102052 Week Low267.75
IndustryPharmaceuticals: OtherVolume3.8 M
SectorHealth TechnologyP/E Ratio TTM18.89
Market Cap78.2 B1 Year Beta0.79
Technical Rating of
Granules India Limited (GRANULES) is a well-established company with a strong track record in the Indian pharmaceutical industry. The company is a leading manufacturer of active pharmaceutical ingredients (APIs) and finished dosages in India. GRANULES has a strong customer base in the Indian and global pharmaceutical markets. GRANULES is well-positioned to capitalize on the growing more about Granules India Limited (GRANULES)

Price1,097.45 -29.85 (-2.65%)52 Week High1,174.50
ISININE326A0103752 Week Low628.00
IndustryPharmaceuticals: OtherVolume1.3 M
SectorHealth TechnologyP/E Ratio TTM51.59
Market Cap513.9 B1 Year Beta0.46
Technical Rating of
Lupin Limited (LUPIN) is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. It was founded in 1968 by Mr. Desh Bandhu Gupta. LUPIN is one of the largest pharmaceutical companies in India, with a market capitalization of over $20 billion. The company manufactures a wide range of generic and branded pharmaceutical products, including anti-infectives, more about Lupin Limited (LUPIN)

Price113.05 2.55 (2.31%)52 Week High155.90
ISININE933A0101452 Week Low88.50
IndustryPharmaceuticals: OtherVolume91,139
SectorHealth TechnologyP/E Ratio TTM
Market Cap3.7 B1 Year Beta0.96
Technical Rating of
Lyka Labs Limited (LYKALABS) is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat. It was founded in 1990 by Mr. Rajesh Shah. LYKALABS is a leading manufacturer of generic APIs (active pharmaceutical ingredients) and finished dosage forms. The company’s products are used in a wide range of therapeutic areas, including anti-infectives, anti-diabetics, and cardiovascular drugs. more about Lyka Labs Limited (LYKALABS)

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock Sectors
Stock Industries